Immunologia Della Neoplasia Uroteliale

Bubenik J. , Perlmann P. , Helmstein K. , Mobergcr G. : Immune response to urinary bladder tumours in man. Intern. J. Cancer, 5; 39 (1970).

Bubenìk J. , Perlmann P. , Helmstein K. , Moberger G. : Cellular and humoral immune responses to human uirnary bladder carcinomas. Intern. J. Cancer, 5; 310 (1970).

Bean M. A. , Pees H. , Fogh J. E. , Grabstald H. , Oettgen H. F. : Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder: detection by a³H-proline microcytotoxicity test. Intern. J. Cancer, 14; 186 (1974).

O'Toole C. , Perlmann P. , Unsgaard B. , Moberger G. , Edsymr F. : Correlation immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy. Intern. J. Cancer, 10; 77 (1972).

O'Toole C. , Perlmann P. , Unsgaard B. , Alhgard L. E. , Johansson B. , Moberger G. , Edsmyr F. : Cellular immunity to human urinary bladder carcinoma. H. Effect of surgery and preoperative irradiation. Intern. J. Cancer, 10; 92 (1972).

O'Toole C. , Perlmann P. , Unsgaard B. , Wigzell H. , Zetterlund C. G. : Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells? Lancet, 1; 1085 (1973).

O'Toole C. , Stejskal V. , Perlmann P. , Karlsson M. : Lymphoid cells mediating tumor-specific citotoxicity to carcinoma of the urinary bladder. Seperation of the effector population using a surface marker. J. exper. med., 139; 457 (1974).

Hakala T. R. , Lange P. M. , Castro A. , Elliott A. , Fraley E. E. : Cell mediated cytotoxicity against human transitional cell carcinomas of the genitourinary tract. Cancer, 34; 1949 (1974).

Catalona W. J. : Commentary on the immunobiology of bladder cancer. J. Urol., 118; 2 (1977).

Burnet M. : Immunological surveillance. Pergamon Press, New York 1970.

De Cenzo J. M. , Allison R. , Leadbetter G. W. Jr. : Skin testing in genitourinary carcinoma; 2-year-followup. J. Urol., 114; 271 (1975).

De Cenzo J. M. , Leadbetter G. W. Jr. : The interaction of host immunocompetence and tumor aggressiveness in superficial bladder carcinoma. J. Urol., 115; 262 (1976).

Catalona J. W. : Prognostic value of host immunocompetence in urologic cancer patients. J. Urol., 114; 922 (1975).

McLaughlin A. P. , Brooks J. D. : Plasma factor inhibiting lymphocyte reactivity in urologic cancer patients. J. Urol., 112; 366 (1974).

Catalona W. J. , Potvin C. , Chretien P. B. : T-lymphocytes in bladder and prostatic cancer patients. J. Urol., 112; 378 (1974).

Herr H. W. , Bean M. A. , Whitmore W. F. Jr. : Decreased ability of blood leukocytes from patients with tumors of the urinary bladder to act as stimulator cells in mixed leukocyte culture. Cancer Res., 36; 2754 (1976).

Sadoughi N. , Rubenstone A. , Mlsna J. , Davidsohn J. : The cell surface antigens of bladder washing specimens in patients with bladder tumors, a new approach. J. Urol., 123; 19 (1980).